Instrument Inactif

Communiqués Peregrine Pharmaceuticals Nasdaq

Actions

US7136613046

Produits pharmaceutiques

Communiqués

10/02/25	Avid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor Experience	AQ
06/02/25	Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners	AQ
05/02/25	Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger	GL
05/02/25	Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners	GL
05/02/25	Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners	AQ
30/01/25	Avid Stockholders Approve Transaction with GHO and Ampersand	GL
22/01/25	Avid Reminds Stockholders to Vote Today FOR the Transaction with GHO and Ampersand	GL
21/01/25	Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis and vote FOR the Transaction with GHO and Ampersand	AQ
21/01/25	Avid Recommends Stockholders Follow Recommendations of ISS and Glass Lewis and vote FOR the Transaction with GHO and Ampersand	GL
08/01/25	Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand	GL
08/01/25	Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand	AQ
07/01/25	AVID BIOSERVICES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avid Bioservices, Inc. - CDMO	BU
31/12/24	Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand	AQ
30/12/24	Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand	GL
18/12/24	Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction	GL
18/12/24	Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction	AQ
11/12/24	Avid Bioservices: Fiscal Q2 Earnings Snapshot	AQ
10/12/24	Avid Bioservices : Reports Financial Results for Second Quarter Ended October 31, 2024 Form 8 K	PU
10/12/24	Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024	AQ
19/11/24	Healthcare & Life Sciences Private Equity Deal Tracker: Ampersand And GHO Acquire Avid Bioservices For $1.1 Billion	AQ
10/11/24	AVID BIOSERVICES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avid Bioservices, Inc. - CDMO	BU
07/11/24	CDMO Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Avid Bioservices to GHO Capital Partners and Ampersand Capital Partners	AQ
07/11/24	Avid Bioservices : to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction Form 8 K	PU
07/11/24	Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction	GL
12/09/24	Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference	AQ